PA
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.526
Exchange
XNAS - Nasdaq
-31 %
Last period ROIC
151%
ROIC has increased in 5 years
What is ROIC ?
The return on invested capital ratio shows how much Net Operating Profit after Tax a company earns per unit of funds involved in its core business. The value of 20% is the benchmark for Eyestock Rating calculation.
See also Pacific Biosciences
Company Analysis
PACB valuation, rating, competitors, insights and company profile
Eyestock Rating
PACB financial analysis by Eyestock methodology
Valuation
PACB valuation using historical relative method
Statements
PACB Income Statements, Balance Sheet and Cash Flow Statements
Dividends
PACB dividend yield and annual dividend
The return on invested capital ratio shows how much Net Operating Profit after Tax a company earns per unit of funds involved in its core business. The value of 20% is the benchmark for Eyestock Rating calculation.
Pacific Biosciences`s ROIC for the last twelve months ended 2024-06-30 is -31 %
